Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
|
+$629M |
| 2 |
AGN
Allergan plc
AGN
|
+$463M |
| 3 |
State Street SPDR S&P Aerospace & Defense ETF
XAR
|
+$350M |
| 4 |
iShares Biotechnology ETF
IBB
|
+$315M |
| 5 |
BPL
Buckeye Partners, L.P.
BPL
|
+$265M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$978M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$675M |
| 3 |
Apple
AAPL
|
+$429M |
| 4 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$387M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$344M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.7% |
| 2 | Healthcare | 5.71% |
| 3 | Financials | 4.62% |
| 4 | Consumer Discretionary | 4.5% |
| 5 | Communication Services | 3.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5426
EverQuote
EVER
$892M
| $92K | ﹤0.01% |
4,334
-1,134
| -21% | -$21.4K |
|
5427
ICL Group
ICL
$6.53B
| $92K | ﹤0.01% |
18,459
-79,122
| -81% | -$394K |
|
|
OPTN
5428
DELISTED
OptiNose
OPTN
| $92K | ﹤0.01% |
872
-199
| -19% | -$19.9K |
|
5429
CALL
Ares Capital
ARCC
$13.5B
| $91K | ﹤0.01% |
4,900
-48,500
| -91% | -$899K |
|
5430
BCB Bancorp
BCBP
$173M
| $91K | ﹤0.01% |
7,123
-2,158
| -23% | -$27.3K |
|
5431
PUT
Cheniere Energy
CQP
$31.9B
| $91K | ﹤0.01% |
2,000
+1,400
| +233% | +$62.2K |
|
5432
IDT Corp
IDT
$1.64B
| $91K | ﹤0.01% |
8,691
-2,859
| -25% | -$28.6K |
|
|
KNDI
5433
Kandi Technologies Group
KNDI
$67.5M
| $91K | ﹤0.01% |
19,562
-59,220
| -75% | -$306K |
|
|
PTN
5434
Palatin Technologies
PTN
$13.7M
| $91K | ﹤0.01% |
80
-24
| -23% | -$28.2K |
|
5435
PUT
Radian Group
RDN
$5.18B
| $91K | ﹤0.01% |
4,000
+3,600
| +900% | +$83.1K |
|
|
MRNS
5436
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $91K | ﹤0.01% |
14,758
+6,670
| +82% | +$53.9K |
|
5437
Alico
ALCO
$280M
| $90K | ﹤0.01% |
2,636
-637
| -19% | -$20.2K |
|
5438
PUT
Compass Minerals
CMP
$1.23B
| $90K | ﹤0.01% |
1,600
-1,100
| -41% | -$59K |
|
5439
Crinetics Pharmaceuticals
CRNX
$8.84B
| $90K | ﹤0.01% |
5,983
-2,650
| -31% | -$51.5K |
|
5440
PUT
Dover
DOV
$27.6B
| $90K | ﹤0.01% |
900
+200
| +29% | +$19.2K |
|
5441
PUT
Icahn Enterprises
IEP
$5.24B
| $90K | ﹤0.01% |
1,400
-700
| -33% | -$49.8K |
|
5442
PUT
Lamar Advertising Co
LAMR
$16.2B
| $90K | ﹤0.01% |
1,100
+900
| +450% | +$71K |
|
5443
Oil-Dri
ODC
$1.44B
| $90K | ﹤0.01% |
5,282
-1,618
| -23% | -$26.8K |
|
5444
Stratus Properties
STRS
$156M
| $90K | ﹤0.01% |
3,074
-833
| -21% | -$22.7K |
|
5445
Unity Bancorp
UNTY
$591M
| $90K | ﹤0.01% |
4,044
-1,167
| -22% | -$24.1K |
|
|
EVBN
5446
DELISTED
Evans Bancorp Inc
EVBN
| $90K | ﹤0.01% |
2,403
-740
| -24% | -$26.3K |
|
|
WIRE
5447
PUT
DELISTED
Encore Wire Corp
WIRE
| $90K | ﹤0.01% |
1,600
+500
| +45% | +$27.7K |
|
5448
Crawford & Co Class A
CRD.A
$532M
| $89K | ﹤0.01% |
8,167
-2,541
| -24% | -$26.1K |
|
5449
PUT
Gogo Inc
GOGO
$565M
| $89K | ﹤0.01% |
14,700
+8,900
| +153% | +$42K |
|
5450
PUT
Nu Skin
NUS
$252M
| $89K | ﹤0.01% |
2,100
-152,800
| -99% | -$6.41M |
|
Similar funds
Barclays's Q3 2019 Portfolio in Review
As of Q3 2019, Barclays held 7,551 positions worth $160B, down 2.1% from $163B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Barclays's Q3 2019 filing shows 501 new, 2,626 increased, 3,452 reduced and 568 closed positions. Its largest new stake was State Street SPDR S&P Aerospace & Defense ETF: 3,300,000 shares worth $353M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $978M.
By sector, the portfolio is most concentrated in Technology at 7.7% of assets, down from 8.5% a quarter earlier, followed by Healthcare and Financials.
- Barclays's largest Q3 2019 buy was State Street SPDR S&P Aerospace & Defense ETF: 3,300,000 shares worth $353M.
- Barclays added most to iPath Series B S&P 500 VIX Short-Term Futures ETN in Q3 2019, an estimated $629M increase.
- Barclays's biggest Q3 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $978M.
- Barclays fully exited Anadarko Petroleum in Q3 2019, selling an estimated $309M.
- Barclays's ten largest holdings make up 28% of its $160B portfolio in Q3 2019.
- Barclays opened 501 new positions and closed 568 in Q3 2019.
- Barclays's portfolio value fell 2.1% quarter-over-quarter to $160B.
Based on Barclays's 13F filing for Q3 2019, filed 14 Nov 2019.